SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-105222
Filing Date
2020-09-15
Accepted
2020-09-15 16:15:24
Documents
12
Period of Report
2020-09-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030862-1_8k.htm   iXBRL 8-K 27107
  Complete submission text file 0001104659-20-105222.txt   202521

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20200914.xsd EX-101.SCH 3219
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20200914_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20200914_pre.xml EX-101.PRE 22732
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2030862-1_8k_htm.xml XML 3598
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 201176151
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences